Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Gottfredsson

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|August 11, 2015
A molecular trigger for intercontinental epidemics of group A StreptococcusLuchang Zhu, Randall J Olsen, Waleed Nasser, et al.
Plos One|October 17, 2012
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based studyAgnar Bjarnason, Gudlaug Thorleifsdottir, Arthur Löve, et al.
Infectious Diseases (London, England)|May 10, 2021
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010-2018Vidar Möller, Åse Östholm-Balkhed, Dag Berild, et al.
Biomedicines|January 21, 2023
Prophylactic Effect of Bovine Colostrum on Intestinal Microbiota and Behavior in Wild-Type and Zonulin Transgenic MiceBirna Asbjornsdottir, Alba Miranda-Ribera, Maria Fiorentino, et al.
Plos One|September 1, 2022
Meals, Microbiota and Mental Health in Children and Adolescents (MMM-Study): A protocol for an observational longitudinal case-control studyBirna Asbjornsdottir, Bertrand Lauth, Alessio Fasano, et al.
The International Journal on Drug Policy|October 25, 2024
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) studySigurdur Olafsson, Thorvardur Jon Love, Ragnheidur Hulda Fridriksdottir, et al.
The Lancet. Gastroenterology & Hepatology|June 25, 2021
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based studySigurdur Olafsson, Ragnheidur H Fridriksdottir, Thorvardur J Love, et al.
AIDS (London, England)|October 6, 2018
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populationsKamilla Grønborg Laut, Leah Shepherd, Magnus Gottfredsson, et al.
HIV Medicine|August 8, 2022
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA studyMyroslava Nikolaichuk, Amanda Mocroft, Gilles Wandeler, et al.
Antiviral Therapy|January 6, 2018
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA studyLars Peters, Amanda Mocroft, Daniel Grint, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|August 11, 2015
A molecular trigger for intercontinental epidemics of group A StreptococcusLuchang Zhu, Randall J Olsen, Waleed Nasser, et al.
Plos One|October 17, 2012
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based studyAgnar Bjarnason, Gudlaug Thorleifsdottir, Arthur Löve, et al.
Infectious Diseases (London, England)|May 10, 2021
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010-2018Vidar Möller, Åse Östholm-Balkhed, Dag Berild, et al.
Biomedicines|January 21, 2023
Prophylactic Effect of Bovine Colostrum on Intestinal Microbiota and Behavior in Wild-Type and Zonulin Transgenic MiceBirna Asbjornsdottir, Alba Miranda-Ribera, Maria Fiorentino, et al.
Plos One|September 1, 2022
Meals, Microbiota and Mental Health in Children and Adolescents (MMM-Study): A protocol for an observational longitudinal case-control studyBirna Asbjornsdottir, Bertrand Lauth, Alessio Fasano, et al.
The International Journal on Drug Policy|October 25, 2024
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) studySigurdur Olafsson, Thorvardur Jon Love, Ragnheidur Hulda Fridriksdottir, et al.
The Lancet. Gastroenterology & Hepatology|June 25, 2021
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based studySigurdur Olafsson, Ragnheidur H Fridriksdottir, Thorvardur J Love, et al.
AIDS (London, England)|October 6, 2018
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populationsKamilla Grønborg Laut, Leah Shepherd, Magnus Gottfredsson, et al.
HIV Medicine|August 8, 2022
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA studyMyroslava Nikolaichuk, Amanda Mocroft, Gilles Wandeler, et al.
Antiviral Therapy|January 6, 2018
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA studyLars Peters, Amanda Mocroft, Daniel Grint, et al.
Pageof 6